Sana Biotechnology Inc.
(SANA)
undefined
undefined%
At close: undefined
1.93
2.39%
After-hours Dec 13, 2024, 07:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -283.25M | -269.48M | -355.93M | -285.31M | -130.78M | -13.25M |
| Depreciation & Amortization | 24.56M | 15.63M | 11.07M | 5.92M | 1.83M | 1K |
| Stock-Based Compensation | 35.53M | 38.34M | 22.36M | 5.83M | 1.50M | 118.00K |
| Other Working Capital | 17.58M | 6.48M | 10.07M | 4.17M | 10.95M | -597.00K |
| Other Non-Cash Items | -49.03M | -82.08M | 61.64M | 129.42M | 38.97M | -228.00K |
| Deferred Income Tax | - | - | - | - | -7.55M | - |
| Change in Working Capital | 18.61M | 7.54M | 9.80M | 6.16M | 10.53M | -308.00K |
| Operating Cash Flow | -253.58M | -290.05M | -251.05M | -137.98M | -85.50M | -13.49M |
| Capital Expenditures | -20.03M | -20.88M | -29.86M | -23.87M | -26.18M | -460.00K |
| Acquisitions | -192.04K | -231.44K | - | 228.69K | -3.19M | - |
| Purchase of Investments | -157.74M | -78.69M | -491.39M | -387.43M | -141.52M | - |
| Sales Maturities Of Investments | 349.79M | 310.13M | 280.02M | 158.74M | 82.98M | - |
| Other Investing Acitivies | 192.04K | 231.44K | -4.57M | -228.69K | 59.00K | -320.00K |
| Investing Cash Flow | 172.01M | 210.56M | -245.80M | -252.56M | -87.86M | -780.00K |
| Debt Repayment | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | - | - | - | 435.69M | 223.72M | - |
| Financial Cash Flow | 31.65M | 4.91M | 631.75M | 435.69M | 223.73M | 45.72M |
| Net Cash Flow | -49.92M | -74.58M | 134.90M | 45.14M | 50.36M | 31.45M |
| Free Cash Flow | -273.61M | -310.93M | -280.92M | -161.85M | -111.69M | -13.96M |